✦ LIBER ✦

Evolution of a new drug formulation: the rationale for high-dose, short-course therapy with azithromycin

✍ Scribed by Jeffrey L. Blumer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An NK1 antagonist versus a 5-HT3 antagon

✍ Van Belle, S.; Hesketh, P.J.; Eldridge, K.; Carides, A.; Horgan, K. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Rationale and design of the LEADERS FREE

✍ Urban, Philip; Abizaid, Alex; Chevalier, Bernard; Greene, Samantha; Meredith, Ia 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 237 KB

Stability studies with a high-performanc

✍ Maria Luisa rossini; Marina Farina 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 478 KB